Genetic markers predicting sulphonylurea treatment outcomes in type 2 diabetes patients: current evidence and challenges for clinical implementation
Crossref DOI link:
Update policy: https://doi.org/10.1007/SPRINGER_CROSSMARK_POLICY
Loganadan, N K
Huri, H Z
Vethakkan, S R
Text and Data Mining valid from 2016-01-26
Version of Record valid from 2016-01-26
1 June 2015
25 October 2015
13 November 2015
26 January 2016
The authors declare no conflict of interest.
Free to read:
This content has been made available to all.